Scholars Central

Conference abstractPublished 7 Nov 2016

EB101 vaccine as a dual immunotherapy for preventing and treating Alzheimerandprime;s disease

Authors: Ivan Carrera, Lucia Fernandez-Novoa, Ivan Tellado, Carmen Vigo, Ramon Cacabelos

EuroEspes Biotechnology, Spain EuroEspes Biomedical Research Center, Spain Atlas Pharmaceuticals, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Amyloid-Ã?² immunization has become one of the most promising immunotherapeutic approaches in the prevention and treatment of Alzheimer's disease (AD) hallmarks, especially the use of active immunization strategies with specific conformations of these proteins has yielded promising results in animal models. However, these prototypes have been clinically unsuccessful when preventing neuroinflammation. Therefore, a new paradigm is needed by using new immuneagents against AD-like pathology, a notion supported by our recent successful active immunotherapy results with adjuvant that induce Th2-only while inhibiting without abrogating Th1 immunity. Here, we discuss the obstacles to AÃ?² 1-42 vaccine (EB101) development and the potential benefits of AÃ?² 1-42 delivered in a novel immunogen-adjuvant composed of niosomescontaining sphingosine-1-phosphate (S1P) that induces regardless of the antigen a safe and effective antibody response, while preventing damaging neuroinflammation and ameliorating pathological degeneration. Chronic administration of EB101 to AD transgenic mice led to a dual immunotherapeutical effect as preventive, before AÃ?² plaques development and treatment action by the significant reduction in amyloid-Ã?² accumulation in both cortical and hippocampal regions when measured by confocal imaging and immunohistochemistry. Therefore, immunization with EB101 has proven neuroprotective effect to prevent and reverse AD-like neuropathology in a significant manner by halting disease progression without developing behavioral deficits in transgenic mice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Human Genetics & Embryology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHuman Genetics & Embryology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Ivan Carrera”
  • BylineArticles whose byline prints “Lucia Fernandez-Novoa”
  • BylineArticles whose byline prints “Ivan Tellado”
  • BylineArticles whose byline prints “Carmen Vigo”
  • BylineArticles whose byline prints “Ramon Cacabelos”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels